Inverse relation between disease severity and expression of the streptococcal cysteine protease, SpeB, among clonal M1T1 isolates recovered from invasive group A streptococcal infection cases

Infection and Immunity

Volumn 68, Issue 11, 2000, Pages 6362-6369

  Kansal, R G ^a   McGeer, A ^a   Low, D E ^a   Norrby Teglund, A ^a   Kotb, M ^a  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL PROTEIN; BACTERIAL PROTEIN M; CYSTEINE PROTEINASE; UNCLASSIFIED DRUG;

ARTICLE; BACTERIAL VIRULENCE; DISEASE SEVERITY; ENZYME ACTIVITY; GENE EXPRESSION REGULATION; HOST PARASITE INTERACTION; HUMAN; NECROTIZING FASCIITIS; NONHUMAN; PRIORITY JOURNAL; STREPTOCOCCUS GROUP A; STREPTOCOCCUS INFECTION; TOXIC SHOCK SYNDROME;

BACTERIAL PROTEINS; CARRIER PROTEINS; CYSTEINE ENDOPEPTIDASES; HUMAN; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS PYOGENES; SUPPORT, U.S. GOV'T, NON-P.H.S.; SUPPORT, U.S. GOV'T, P.H.S.; VIRULENCE;

EID: 0033791996     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.68.11.6362-6369.2000     Document Type: Article

References (45)

1. The family of mitogenic, shock-inducing and superantigenic toxins from Staphylococci and Streptococci
2. Molecular analysis of the role of the group A streptococcal cysteine protease, hyaluronic acid capsule, and M protein in a routine model of human invasive soft-tissue infection
3. Risk factors in the pathogenesis of invasive group A streptococcal infections: Role of protective humoral immunity
4. Peptic digestion of streptococcal M protein. II. Extraction of M antigen from group A streptococci with pepsin
5. Streptococcal cysteine proteinase releases biologically active fragments of streptococcal surface proteins
6. Role of emm and mrp genes in the virulence of group A streptococcal isolate 64/14 in a mouse model of skin infection
7. Activation of 66-kilodalton human endothelial cell matrix metalloprotease by Streptococcus pyogenes extracellular cysteine protease
8. Genetic relatedness and superantigen expression in group A streptococcus serotype M1 isolates from patients with severe and nonsevere invasive diseases
9. Genetic and phenotypic diversity among isolates of Streptococcus pyogenes from invasive infections
10. Invasive group A streptococcal infections in Ontario, Canada
11. Severe invasive group A streptococcal infections in Ontario, Canada: 1987-1991
12. A response regulator that represses transcription of several virulence operons in the group A streptococcus
13. A two-component regulatory system, CsrR-CsrS, represses expression of three Streptococcuspyogenes virulence factors, hyaluronic acid capsule, streptolysin S, and pyrogenic exotoxin B
14. Streptococcal cysteine proteinase releases kinins: A virulence mechanism
15. The changing epidemiology of invasive group A streptococcal infections and the emergence of streptococcal toxic shock-like syndrome. A retrospective population-based study
16. Vaccination with streptococcal extracellular cysteine protease (interleukin-1 beta convertase) protects mice against challenge with heterologous group A streptococci
17. Cleavage of interleukin 1β (IL-1β) precursor to produce active IL-1β by a conserved extracellular cysteine protease from Streptococcus pyogenes
18. A conserved Streptococcus pyogenes extracellular cysteine protease cleaves human fibronectin and degrades vitronectin
19. Bacterial pyrogenic exotoxins as superantigens
20. Role of superantigens in the pathogenesis of infectious diseases and their sequelae
21. Role of streptococcal pyrogenic exotoxin B in the mouse model of group A streptococcal infection
22. Identification of csrR/csrS, a genetic locus that regulates hyaluronic acid capsule synthesis in group A Streptococcus
23. Identification of pel, a Streptococcus pyogenes locus that affects both surface and secreted proteins
24. Genetic inactivation of an extracellular cysteine protease (SpeB) expressed by Streptococcus pyogenes decreases resistance to phagocytosis and dissemination to organs
25. Extracellular cysteine protease produced by Streptococcus pyogenes participates in the pathogenesis of invasive skin infection and dissemination in mice
26. Inactivation of Streptococcus pyogenes extracellular cysteine protease significantly decreases mouse lethality of serotype M3 and M49 strains
27. A role for trigger factor and an rgg-like regulator in the transcription, secretion and processing of the cysteine proteinase of Streptococcus pyogenes
28. A novel superantigen isolated from pathogenic strains of Streptococcus pyogenes with amino-terminal homology to staphylococcal enterotoxins B and C
29. Streptococcal pyrogenic exotoxin A, streptolysin O, exoenzymes, serotype and biotype profiles of Streptococcus pyogenes isolates from patients with toxic shock syndrome and other severe infections
30. Geographic and temporal distribution and molecular characterization of two highly pathogenic clones of Streptococcus pyogenes expressing allelic variants of pyrogenic exotoxin A (Scarlet fever toxin)
31. Genetic diversity in T1M1 group A streptococci in relation to clinical outcome of infection
32. Plasma from patients with severe invasive group A streptococcal infections treated with normal polyspecific IgG inhibits streptococcal superantigen-induced T cell proliferation and cytokine production
33. Identification and characterization of novel superantigens from Streptococcus pyogenes
34. Association of type II immunoglobulin G-binding protein expression and survival of group A streptococci in human blood
35. Properties of IgG-binding proteins expressed by Streptococcus pyogenes isolates are predictive of invasive potential
36. Absence of SpeB production in virulent large capsular forms of group A streptococcal strain 64
37. A secreted streptococcal cysteine protease can cleave a surface-expressed M1 protein and alter the immunoglobulin binding properties
38. Protein GRAB of Streptococcus pyogenes regulates proteolysis at the bacterial surface by binding α2-macroglobulin
39. Role of superantigens in human diseases
40. Comparison of pathogenic factors expressed by group A Streptococci isolated from patients with streptococcal toxic shock syndrome and scarlet fever
41. Invasive group A streptococcus infections
42. Severe group A streptococcal infections associated with a toxic shock-like syndrome and scarlet fever toxin A
43. Association of phenotypic and genotypic characteristics of invasive Streptococcus pyogenes isolates with clinical components of streptococcal toxic shock syndrome
44. Proteolytically active streptococcal pyrogenic exotoxin B cleaves monocytic cell urokinase receptor and releases an active fragment of the receptor from the cell surface
45. Defining the group A streptococcal toxic shock syndrome. Rationale and consensus definition